Discovery Research Platform for Infection

The Discovery Research Platform for Infection fosters investigator-led approaches via the overarching scientific objective of combatting infection, especially HIV-1, tuberculosis (TB) and lower respiratory infections including COVID-19, through clinical and laboratory research. The Platform also supports research on the interaction between communicable and non-communicable diseases, especially where the latter impact susceptibility to infection, or arise as a consequence of infection. In particular, the Discovery Research Platform for Infection improves understanding and management of the challenges of antiretroviral therapy (ART) such as metabolic complications and drug interactions.

The Discovery Research Platform for Infection is administered by the Centre for Infectious Diseases Research in Africa, based within the Institute of Infectious Disease and Molecular Medicine (IDM) in the Faculty of Health Sciences at the University of Cape Town (UCT).